
A comprehensive analysis using the SEER database has shed light on the significant impact of gender on survival outcomes in patients with small intestinal stromal tumors (SISTs). This study analyzed 3513 patients, revealing that male patients have a significantly higher mortality rate compared to female patients. Kaplan-Meier and Cox proportional hazard models demonstrated that female patients have superior overall survival (OS) and cancer-specific survival (CSS) rates. The data suggest that surgical intervention improves 5-year OS and CSS rates in both genders, but the overall prognosis remains poorer for males. These findings underscore the necessity of incorporating gender-specific considerations into the management and treatment strategies for SIST patients. Further research may be needed to explore the underlying biological mechanisms driving these differences. Access the full study here.
Get free health updates from Dr Harsh Shah on WhatsApp
Swasth Parivar: twice a month, practical advice on recovery, diet and warning signs. No advertising. Stop any time.
Your number is used for these updates and for the clinic to reach you. It is never sold or passed on. To stop, reply STOP on WhatsApp.
Leave a Reply